Currently predicting for Thu, 4 Jun 2026

ABBV Prediction Chart

ABBV Predictions History

Latest community submissions for ABBV.
Predictor Target Session Target Price Result Direction Accuracy Score
Feb 10, 2023 $147.50 -0.81% $152.05 X 97.01% 0
Feb 10, 2023 $147.95 -0.50% $152.05 X 97.30% 0
AlexVel AlexVel Pro
Jan 17, 2023 $154.21 +0.40% $152.64 X 98.97% 1
JS JS Pro
Jan 17, 2023 $154.11 +0.33% $152.64 X 99.03% 1
Jan 17, 2023 $154.90 +0.85% $152.64 X 98.52% 1
Jan 17, 2023 $154.41 +0.53% $152.64 X 98.84% 1
elizabeth hironaka elizabeth hironaka @elizabethhironaka.252606
Jan 6, 2023 Bullish $166.55 V 1
JS JS Pro
Dec 22, 2022 $162.34 +0.08% $162.84 V 99.69% 5
Dec 22, 2022 $160.67 -0.95% $162.84 X 98.67% 1
Dec 22, 2022 $162.51 +0.18% $162.84 V 99.80% 6
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ABBV with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ABBVIE INC
AbbVie
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE